Viatris, Inc. (VTRS)
16.51
+0.17
(+1.04%)
USD |
NASDAQ |
Aug 31, 16:00
16.50
-0.01
(-0.06%)
After-Hours: 04:58
Viatris Cash from Operations (TTM) : 2.331B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.331B |
| March 31, 2026 | 2.169B |
| December 31, 2025 | 2.316B |
| September 30, 2025 | 1.983B |
| June 30, 2025 | 2.064B |
| March 31, 2025 | 2.224B |
| December 31, 2024 | 2.303B |
| September 30, 2024 | 2.300B |
| June 30, 2024 | 2.307B |
| March 31, 2024 | 2.443B |
| December 31, 2023 | 2.800B |
| September 30, 2023 | 2.463B |
| June 30, 2023 | 2.498B |
| March 31, 2023 | 2.785B |
| December 31, 2022 | 2.953B |
| September 30, 2022 | 3.333B |
| June 30, 2022 | 3.550B |
| March 31, 2022 | 3.307B |
| December 31, 2021 | 3.017B |
| September 30, 2021 | 2.53B |
| June 30, 2021 | 1.969B |
| March 31, 2021 | 1.790B |
| December 31, 2020 | 1.232B |
| September 30, 2020 | 1.882B |
| June 30, 2020 | 1.845B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.134B |
| December 31, 2019 | 1.804B |
| September 30, 2019 | 1.753B |
| June 30, 2019 | 1.919B |
| March 31, 2019 | 1.680B |
| December 31, 2018 | 2.342B |
| September 30, 2018 | 2.201B |
| June 30, 2018 | 2.096B |
| March 31, 2018 | 2.237B |
| December 31, 2017 | 2.065B |
| September 30, 2017 | 1.919B |
| June 30, 2017 | 2.571B |
| March 31, 2017 | 2.416B |
| December 31, 2016 | 2.047B |
| September 30, 2016 | 2.350B |
| June 30, 2016 | 2.124B |
| March 31, 2016 | 1.822B |
| December 31, 2015 | 2.008B |
| September 30, 2015 | 1.483B |
| June 30, 2015 | 949.00M |
| March 31, 2015 | 1.014B |
| December 31, 2014 | 1.015B |
| September 30, 2014 | 1.306B |
| June 30, 2014 | 1.280B |
| March 31, 2014 | 1.287B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Pfizer Inc. | 13.40B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |
| Bristol Myers Squibb Co. | 12.78B |
| Johnson & Johnson | 27.61B |